With a distinguished career in finance, Brian Durkin has established himself as an influential figure within the capital markets landscape. He possesses extensive experience across various roles in investment banking and corporate strategy, contributing to numerous successful transactions and strategic initiatives. His adept leadership is characterized by a deep understanding of market dynamics and regulatory frameworks, enabling him to drive growth in both emerging and established businesses. Known for his strong network of industry relationships, he consistently identifies opportunities for collaboration that enhance value creation. Durkin’s commitment to excellence ensures he remains at the forefront of developments within financial services.
With a distinguished career in finance, Brian Durkin has established himself as an influential figure within the capital markets landscape. He possesses extensive experience across various roles in investment banking and corporate strategy, contributing to numerous successful transactions and strategic initiatives. His adept leadership is characterized by a deep understanding of market dynamics and regulatory frameworks, enabling him to drive growth in both emerging and established businesses. Known for his strong network of industry relationships, he consistently identifies opportunities for collaboration that enhance value creation. Durkin’s commitment to excellence ensures he remains at the forefront of developments within financial services.
| Trades 91 | Longs Won 42/91 46% | Profit Factor 13.97 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $8.28M |
| Average Win $8.91M | Best Trade (Oct 15) $42.04M | Sharpe Ratio 0 |
| Average Loss -$546,808.23 | Worst Trade (Oct 15) -$6.09M | Z-Score -0.79 (57.12%) |
| Commissions $0 | Avg. Trade Length 25y 9m 3w 3d | Expectancy $3.82M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.17% |
| Consecutive Losing Trades | 1,001 | 901 | 801 | 701 | 601 | 501 | 400 | 300 | 200 | 100 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 0266 026609107 | 3,265 | $207,000 | $207,000 | - | - | - | 0.0 |
| 2061 206197105 | 5,000 | $220,000 | $220,000 | - | - | - | 0.0 |
| 6040 604059105 | 1,741 | $210,000 | $210,000 | - | - | - | 0.0 |
| 7171 71713U102 | 12,200 | $744,000 | $744,000 | - | - | - | 0.0 |
| 9180 918005109 | 16,550 | $513,000 | $513,000 | - | - | - | 0.0 |
| 9470 947074100 | 27,350 | $1.29M | $1.29M | - | - | - | 0.0 |
| ABI ABI | 7,650 | $720,000 | $720,000 | - | - | - | 0.0 |
ADBE Adobe Inc. | 67,644 | $1.97M | $16.28M | - | $14.31M | 727.28% | +1.862% |
| ADCT ADCT | 184,340 | $3.34M | $3.34M | - | - | - | 0.0 |
AIG American International Group Inc. | 3,651.2 | $6.37M | $283,515.68 | - | -$6.09M | -95.55% | 0.0 |
| ALTR ALTR | 48,100 | $1.27M | $1.27M | - | - | - | 0.0 |
AMGN Amgen Inc. | 85,243 | $5.45M | $35.19M | - | $29.74M | 545.72% | 0.0 |
AVP Avon Products Inc | 153,230 | $3.67M | $7.34M | - | $3.67M | 100% | 0.0 |
BMY Bristol-Myers Squibb Company | 5,883.5 | $413,998.22 | $348,773.76 | - | -$65,224.46 | -15.75% | +4.606% |
| BOW BOW | 14,550 | $820,000 | $820,000 | - | - | - | 0.0 |
BP BP p.l.c. Sponsored ADR | 8,681 | $416,000 | $423,719.61 | - | $7,719.61 | 1.86% | +0.577% |
| BR BR | 33,860 | $1.71M | $1.71M | - | - | - | 0.0 |
| BRCD BRCD | 2,200 | $202,000 | $202,000 | - | - | - | 0.0 |
BUD Anheuser-Busch InBev S.A. ADR | 59,210 | $2.69M | $4.71M | - | $2.01M | 74.73% | +1.119% |
C Citigroup Inc. | 12,641.2 | $6.46M | $1.55M | - | -$4.91M | -76.06% | -1.815% |